Skip to main content
. 2021 Jan 15;16(5):484–490. doi: 10.1159/000512840

Table 1.

Patient characteristics (n = 51)

Age at diagnosis, years 45 [35–51]
Number of children 4 (0–11)
Walking time to health center, h 1.1 (0.1–3)
Travel time to hospital, h 6.1 (0.1–24)
Age group 11 (22)
 <35 years
 35–50 years 25 (49)
 >50 years 15 (29)
Premenopausal 24 (47)
Postmenopausal 27 (53)
Place of residence (n = 48)
 Rural 38 (79)
 Urban 10 (21)
Religion (n = 48)
 Christian 38 (79)
 Muslim 9 (19)
 Other 1 (2)
Literate (n = 38)
 No 31 (77)
 Yes 9 (23)
Profession (n = 49)
 Housewife 28 (57)
 Farmer 17 (35)
 Student 1 (2)
 Other 3 (6)
Marital status (n = 41)
 Married 38 (93)
 Not married 3 (7)
Survival status
 Deceased 21 (46)
 Alive 21 (35)
 Unknown 9 (18)
AJCC stage (n = 33)
 1 2 (6)
 2 10 (30)
 3 20 (61)
 4 1 (3)
Clinical tumor size (n = 38)
 T1 3 (6)
 T2 22 (46)
 T3 18 (38)
 T4 5 (10)
Pathological diagnosis
 NST 47 (92)
 Other 4 (8)
Grading
 Grade 1 3 (6)
 Grade 2 14 (27)
 Grade 3 34 (67)
HR status
 ER+PgR+ 28 (55)
 ER+PgR– 9 (18)
 ER–PgR+ 12 (23)
 Unknown 2 (4)
HER2
 Negative (0 to 2+) 39 (76)
 Positive (3+) 10 (20)
 Unknown 2 (4)
Ki-67
 Negative (<14%) 16 (31)
 Positive 33 (65)
 Unknown 2 (4)
Surgical treatment (n = 44)
 Modified radical mastectomy 15 (34)
 Simple mastectomy 4 (9)
 Radical mastectomy 1 (2)
 Lumpectomy1 7 (16)
 Quadrantectomy1 6 (14)
 Mastectomy (not specified) 11 (25)

Data are presented as the mean [IQR], mean (range), or n (%). AJCC, American Joint Committee on Cancer; ER, estrogen receptor; PgR, progesterone receptor; NST, non-specific type of BC.

1

No irradiation in breast-conserving therapy.